Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

COPD

Interventions

DRUG

QAB149

Trial Locations (2)

Radiant Research, Boise

Radiant Research, Encinitas